Meridian Bioscience acquires BreathTek business from Otsuka for $20M

Meridian Bioscience signed a definitive agreement to acquire the North American BreathTek business from Otsuka America Pharmaceutical for $20 million in cash. The acquisition includes customer relationships for the urea breath test for H. pylori detection.

“This is another example of our strategic use of cash generated during the pandemic to further position the diagnostics segment for sustainable growth.”globenewswire.com

• 1 source
• globenewswire.comMeridian Signs Definitive Agreement to Acquire Urea BreathMeridian Bioscience Inc.Jul 23, 2021

Summarized from public sources; check the original articles before acting on it.